British venture the Dementia Discovery Fund (DDF) has received a $50 million investment from Bill Gates, to help fuel progress toward disease-modifying therapies for Alzheimer’s disease.
The world already has a supersuccessful pneumococcal conjugate vaccine in Pfizer's Prevnar 13, but that isn't stopping PnuVax from pushing ahead with its own program.
It has been announced that the Bill & Melina Gates Foundation will invest up to $40 million in UK-based Immunocore to support the development of therapeutics for infectious diseases.